CORAL SPRINGS, Fla. — Nutra Pharma Corp.’s Cobroxin over-the-counter pain reliever for moderate to severe chronic pain is now on shelves at more than 7,000 CVS drug stores nationwide.

"We are excited to announce the availability of Cobroxin in CVS, as this represents the first major drug store chain to carry Cobroxin nationwide," Rik Deitsch, chairman and chief executive officer of Nutra Pharma, said in a statement.

"As an OTC, non-narcotic, and nonaddictive analgesic, we believe that Cobroxin will become the treatment of choice among those suffering from moderate to severe chronic pain," Deitsch added.

Nutra Pharma last year granted an exclusive license to Delray Beach, Fla.-based XenaCare Holdings to market and distribute Cobroxin in the United States. Earlier this month, XenaCare announced that Cobroxin will be available in Walgreens stores across the country by May 1.

According to the companies, Cobroxin is the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain, whereas many other Stage 2 drugs — such as Tylenol 3, Percocet and Vicodin — require prescriptions.

An all-natural medication, Cobroxin is available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain and neuralgia. It also comes in a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

In March, XenaCare announced that Cobroxin Advanced Topical Gel became available at Duane Reade. And in February, the company said food and drug retailers Winn-Dixie, Hannaford and Sweetbay Supermarkets began carrying Cobroxin.

XenaCare reported in late January that it expanded its national advertising campaign to support the growing network of retailers carrying Cobroxin.